SCHEMBL4835225

SCHEMBL4835225

COP(=O)(Cc1ccc(NC(=O)CCc2cnn(C)c2-c2ccc(F)cc2)cc1)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.41
HTR2A P28223 2/20 0.40
HTR2C P28335 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
RXFP1 Q9HBX9 2/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC10 Q969S8 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
ALDH1A1 P00352 2/20 0.37
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
MALT1 Q9UDY8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4836516 0.91 MCHR1 (0.40) MCHR1HTR2AHTR2CMEN1KMT2A
SCHEMBL4826251 0.91 HTR2A (0.42) MCHR1HTR2AHTR2CMEN1KMT2A
SCHEMBL4831113 0.90 ENPP2 (0.46) MCHR1HTR2AHTR2CMEN1KMT2A
SCHEMBL4837050 0.82 MAPT (0.41) MCHR1HTR2AHTR2CMEN1KMT2A
SCHEMBL4833889 0.81 CCNC (0.42) HTR2AHTR2CKMT2ALMNAHDAC1
SCHEMBL4835215 0.80 RXFP1 (0.40) MCHR1HTR2AHTR2CMEN1KMT2A
SCHEMBL5770235 0.80 MCHR1 (0.40) MCHR1MEN1KMT2ARXFP1MAPK1
SCHEMBL4834035 0.80 ENPP2 (0.46) MCHR1HTR2AHTR2CMEN1KMT2A
SCHEMBL4836511 0.79 RAB9A (0.38) MCHR1HTR2AHTR2CMEN1KMT2A
SCHEMBL4836713 0.75 CYP11B1 (0.48) MCHR1MEN1KMT2ARXFP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287438-A1 Agent for preventing or treating neuropathy MOMOSE YU 2008-11-20 US disclosed
US-7423159-B2 Agent for preventing or treating neuropathy TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-09-09 US disclosed
US-20060004069-A1 Agent for preventing or treating neuropathy TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004069-A1 Agent for preventing or treating neuropathy NR2C2, NR0B2, NR2E1 MCHR1 990/4885HTR2A 906/4885HTR2C 737/4885
US-20080287438-A1 Agent for preventing or treating neuropathy NR2C2, NR0B2, NR2E1 MCHR1 990/4885HTR2A 906/4885HTR2C 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.